PentaBind

Drugging the Undruggable with Generative AI and Aptamer Therapeutics

[PentaBind @pentabind]

Cracking the 30-year problem of aptamer commercialisation will enable the detection and targeting of almost any molecule of interest. This will open up a plethora of markets and products within precision medicine, therapeutic design and portable biosensing
#aptamers #AI #startup

[PentaBind @pentabind]

🔬 How Aptamers Bind to Their Targets 🔬

#Aptamers are revolutionising #biotechnology and #medicine with their incredible ability to bind to specific targets with high affinity and specificity. But how do they achieve this? Here's a breakdown of the binding mechanisms.

[PentaBind @pentabind]

Aptamers vs. Antibodies: Both #aptamers and #antibodies offer distinct advantages, making them valuable in different contexts within #biotechnology and #medical science. By understanding their unique properties, we can better leverage their strengths for specific applications.

[PentaBind @pentabind]

🌟 Exciting news from #PentaBind! 🌟 We're expanding and recruiting for key roles at the Scale Space Careers Fair on May 15. Meet our CEO Rory & CTO Phil to discuss the future of AI in drug discovery. 🚀 Join us to help craft novel therapies! #tech #techbio #ai #startups

[PentaBind @pentabind]

🚀 Excited to share that PentaBind has joined
@NVIDIA Inception, a program nurturing startups revolutionising industries! With NVIDIA, we aim to accelerate drug discovery and improve cancer therapeutics. More info at https://t.co/IX56dK7KBw #AI #DrugDiscovery #nvidiainception

[PentaBind @pentabind]

Happy #DNADay! Today we celebrate the remarkable discovery of the DNA double helix in 1953 and the incredible advancements in genomics since. From personalised medicine to groundbreaking research, DNA continues to unlock mysteries of life. What’s your favorite DNA fact? #Genomics

[PentaBind @pentabind]

We are thrilled to announce that PentaBind has been awarded a grant from UKRI! This funding will enable significant advancements in our wet-laboratory processes and therapeutic pipeline through the integration of AI technologies. #UKRI #accelerator #biotech #Innovation

[PentaBind @pentabind]

🌟 Big news! #PentaBind is growing 🚀. Last month, we welcomed three new members to our team. We are now a powerhouse team of six, we're set for new heights! Each brings invaluable knowledge & skills, perfectly aligned with our innovation journey. Excited for what's ahead!

[The Aptamers Journal - Making aptamers great! @JAptamers]

Job vacancy at @pentabind (London, UK)

Job title: #Biopharmaceutical Scientist (Part-Time or Full-Time)

Further information at: https://t.co/fZs1DtzHXp

[The Aptamer Society @AptamerSociety]

Job vacancy at @pentabind (London, UK)

Job title: #Biopharmaceutical Scientist (Part-Time or Full-Time)

Further information at:
https://t.co/J6AWrI20hF